TAF4B
Transcription initiation factor TFIID subunit 4B
Also known as: TAF2C2, TAF4B_HUMAN, TAFII105
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92750
- Gene
- TAF4B
- Ensembl
- ENSG00000141384
- Chromosome
- 18
- Canonical length
- 862 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center
- Quaternary structure
- Homodimer
OverviewNCBI Gene
TATA binding protein (TBP) and TBP-associated factors (TAFs) participate in the formation of the TFIID protein complex, which is involved in initiation of transcription of genes by RNA polymerase II. This gene encodes a cell type-specific TAF that may be responsible for mediating transcription by a subset of activators in B cells. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
Canonical amino-acid sequenceUniProt
862 residues, UniProt reviewed canonical sequence.
>Q92750|TAF4B
1 MPAGLTEPAG AAPPAAVSAS GTVTMAPAGA LPVRVESTPV ALGAVTKAPV SVCVEPTASQ
61 PLRSPVGTLV TKVAPVSAPP KVSSGPRLPA PQIVAVKAPN TTTIQFPANL QLPPGTVLIK
121 SNSGPLMLVS PQQTVTRAET TSNITSRPAV PANPQTVKIC TVPNSSSQLI KKVAVTPVKK
181 LAQIGTTVVT TVPKPSSVQS VAVPTSVVTV TPGKPLNTVT TLKPSSLGAS STPSNEPNLK
241 AENSAAVQIN LSPTMLENVK KCKNFLAMLI KLACSGSQSP EMGQNVKKLV EQLLDAKIEA
301 EEFTRKLYVE LKSSPQPHLV PFLKKSVVAL RQLLPNSQSF IQQCVQQTSS DMVIATCTTT
361 VTTSPVVTTT VSSSQSEKSI IVSGATAPRT VSVQTLNPLA GPVGAKAGVV TLHSVGPTAA
421 TGGTTAGTGL LQTSKPLVTS VANTVTTVSL QPEKPVVSGT AVTLSLPAVT FGETSGAAIC
481 LPSVKPVVSS AGTTSDKPVI GTPVQIKLAQ PGPVLSQPAG IPQAVQVKQL VVQQPSGGNE
541 KQVTTISHSS TLTIQKCGQK TMPVNTIIPT SQFPPASILK QITLPGNKIL SLQASPTQKN
601 RIKENVTSCF RDEDDINDVT SMAGVNLNEE NACILATNSE LVGTLIQSCK DEPFLFIGAL
661 QKRILDIGKK HDITELNSDA VNLISQATQE RLRGLLEKLT AIAQHRMTTY KASENYILCS
721 DTRSQLKFLE KLDQLEKQRK DLEEREMLLK AAKSRSNKED PEQLRLKQKA KELQQLELAQ
781 IQHRDANLTA LAAIGPRKKR PLESGIEGLK DNLLASGTSS LTATKQLHRP RITRICLRDL
841 IFCMEQEREM KYSRALYLAL LKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TAF4B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 4.3 nTPM
Expression across tissuesHPA
Tissue
- testis: 4.3 nTPM
- tonsil: 3 nTPM
- lymph node: 2.9 nTPM
- bone marrow: 2.7 nTPM
- appendix: 2.6 nTPM
- ovary: 2.6 nTPM
Single-cell type
- endometrial luminal cells: 440 nCPM
- endometrial glandular cells: 267 nCPM
- endometrial ciliated cells: 244 nCPM
- choroid plexus epithelial cells: 216 nCPM
- erythrocyte progenitors: 205 nCPM
- basal keratinocytes: 198 nCPM
Immune cell
- memory B-cell: 2.3 nTPM
- naive B-cell: 2 nTPM
- naive CD4 T-cell: 2 nTPM
- naive CD8 T-cell: 1.6 nTPM
- MAIT T-cell: 1 nTPM
- memory CD8 T-cell: 1 nTPM
Brain region
- cerebral cortex: 10 nTPM
- pons: 8.6 nTPM
- white matter: 7.7 nTPM
- basal ganglia: 6.6 nTPM
- cerebellum: 6.1 nTPM
- medulla oblongata: 6.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TAF4B.
Disease | AllUniProt
Conditions TAF4B is implicated in, by any mechanism.
- Spermatogenic failure 13 (SPGF13) MIM:615841
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 182 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spermatogenic failure 13
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.23
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA transcription by RNA polymerase II
- oogenesis
- positive regulation of transcription initiation by RNA polymerase II
- RNA polymerase II preinitiation complex assembly
- spermatogenesis
- transcription initiation at RNA polymerase II promoter
Molecular functions
- DNA binding
- NF-kappaB binding
- protein heterodimerization activity
- RNA polymerase II general transcription initiation factor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TAF4B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TAF4B as an antibody target. Whether an autoantibody or antibody against TAF4B could matter depends on whether native TAF4B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TAF4B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TAF4B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...